New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

43

Takeda’s Exkivity Approved by U.S. FDA as First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion+ NSCLC

The U.S. Food and Drug Administration approved Takeda Pharmaceutical Company Limited’s Exkivity (mobocertinib) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.

45

FDA staff say Pfizer COVID-19 boosters may not be needed, but do improve immunity

U.S. Food and Drug Administration scientists said on Sept. 15 that booster doses of Pfizer’s Covid-19 vaccine may not be needed, even though the third shot generates a higher immune response in recipients.

46

Study: Survivors of Severe COVID-19 at Risk for Autoimmune Disease

A study published in Nature Communications reveals that patients who had been hospitalized with severe Covid-19 might not be totally safe after recovery, as they are more likely to harbor self-attacking antibodies than those who did not have the virus.

47

Shaheed Peera Joins FCB Health Europe as Global Creative Partner 

IPG Health CEO Dana Maiman announced that Shaheed Peera joined FCB Health Europe as Global Creative Partner. Best known as founder of the Creative Floor Awards, in addition to other countless achievements, Peera will partner with creative leaders, championing collaboration, diversity & inclusion and continued unparalleled creative excellence across the FCB Health family of agencies.

49

Sanofi Shutters Principia’s San Francisco Labs After BTK Failure

According to a California WARN notice, Sanofi is shuttering Principia Biopharma’s laboratories in San Francisco and laying off about three dozen employees after the Phase III PEGASUS trial failure of rilzabrutinib for pemphigus.

50

Merck and Otsuka Recognized for Driving Greater Equality for Women in the Workplace by Healthcare Businesswomen’s Association

With gender inequality a continued area of focus for corporations and workplaces around the globe, the Healthcare Businesswomen’s Association (HBA) recognized Merck & Co. Inc. and Otsuka America Pharmaceutical Inc. for exemplary workplace initiatives working to close the gender gap in the healthcare and life science industries.